Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 4th Quarter - Report (No Activity)

CARY PHARMACEUTICALS

via THE CONAFAY GROUP, LLC

4th Quarter (Oct 1 - Dec 31) · 2012Posted Jan 10, 2013Filing document ↗LDA record ↗

Income$20Kfee reported

Client

Name: CARY PHARMACEUTICALS
Description: a pharmaceutical development company-smoking cessationm catheter technology
Location: Virginia · United States of America

Registrant

Firm: THE CONAFAY GROUP, LLC
Description: Life Sciences Consulting Firm
Location: Washington, District of Columbia, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

CARY PHARMACEUTICALS — Lobbying — Receipts Report